Items per page
1 - 229 of 229
Title Published in Access level OA Policy Year Views Downloads
Alliance thérapeutique et thérapie cognitivo-comportementale de groupeRevue médicale suisse
accessLevelPublic
2023 98 190
Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 VaccineActa haematologica
accessLevelPublic
2023 62 56
Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with TramadolPharmaceuticals
accessLevelPublic
2023 59 32
Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocolFrontiers in pain research
accessLevelPublic
2023 118 65
Is massage a legitimate part of nursing care ? A qualitative studyPloS one
accessLevelPublic
2023 67 111
Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in HumansGenome biology and evolution
accessLevelPublic
2022 508 129
Opioid‐related adverse drug reactions in patients visiting the emergency division of a tertiary hospitalPharmacology research & perspectives
accessLevelPublic
2022 147 72
Hydromorphone Prescription for Pain in Children - What Place in Clinical Practice?Frontiers in pediatrics
accessLevelPublic
2022 172 63
Case report: Confirming a diagnosis of severe olmesartan-associated enteropathyThérapie
accessLevelRestricted
2022 199 0
Dexamethasone for the treatment of established postoperative nausea and vomiting: A randomised dose finding trialEuropean journal of anaesthesiology
accessLevelPublic
2022 348 154
Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spotsClinical and translational science
accessLevelPublic
2022 232 133
Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trialClinical and translational science
accessLevelPublic
2022 141 89
Uncovering a Genetic Polymorphism Located in Huntingtin Associated Protein 1 in Modulation of Central Pain Sensitization Signaling PathwaysFrontiers in neuroscience
accessLevelPublic
2022 404 74
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World SettingJournal of personalized medicine
accessLevelPublic
2022 213 198
Genetic Susceptibility Toward Nausea and Vomiting in Surgical PatientsFrontiers in genetics
accessLevelPublic
2022 229 131
Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patientsFrontiers in aging neuroscience
accessLevelPublic
2022 83 59
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokineticsCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2022 263 374
Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva CocktailClinical pharmacology and therapeutics
accessLevelPublic
2021 200 124
Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult PatientsDrugs
accessLevelPublic
2021 239 239
Activité, décentration et restructuration cognitive dans la thérapie cognitivocomportementale. Éléments pour la pratique cliniqueRevue médicale suisse
accessLevelPublic
2021 371 1,072
CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical SettingFrontiers in pharmacology
accessLevelPublic
2021 269 194
Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in SwitzerlandFrontiers in Psychiatry
accessLevelPublic
2021 304 393
The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker?Journal of personalized medicine
accessLevelPublic
2021 217 49
Opioïdes monoaminergiques : lequel choisir ?Revue médicale suisse
accessLevelPublic
2021 174 134
Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the LiteratureFrontiers in pharmacology
accessLevelPublic
2021 210 345
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activityBritish journal of pharmacology
accessLevelPublic
2021 314 129
Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MSJournal of chromatography. B
accessLevelPublic
2021 415 357
Impacts of touch massage on the experience of patients with chronic pain: a protocol for a mixed method studyComplementary therapies in clinical practice
accessLevelRestricted
2021 279 1
Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic ReviewClinical pharmacokinetics
accessLevelPublic
2021 219 160
Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging TrendsFrontiers in pharmacology
accessLevelPublic
2021 175 181
Cannabinoids and COVID-19Medical Cannabis and Cannabinoids
accessLevelPublic
2020 249 141
Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic OriginsDrug Safety
accessLevelPublic
2020 703 225
Mise au point sur la prise en charge de la douleur chez les patients adultes atteints de déficience intellectuelleDouleur et analgésie
accessLevelRestricted
2020 50 1
Outcomes of drug exposition during pregnancy: Analysis from a teratology information serviceEuropean Journal of Obstetrics, Gynecology, and Reproductive Biology
accessLevelRestricted
2020 269 4
Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva CocktailClinical Pharmacology and Therapeutics
accessLevelPublic
2020 322 431
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteersEuropean Journal of Pain
accessLevelRestricted
2020 249 1
Opioïdes chez les patients âgés: Faux-amis ?La gazette médicale - info@gériatrie
accessLevelRestricted
2020 241 1
The Role of Demoralization and Meaning in Life (DEMIL) in Influencing Suicidal Ideation Among Patients Affected by Chronic Pain: Protocol of a Single-Center, Observational, Case-Control StudyJMIR Research Protocols
accessLevelPublic
2020 394 193
Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytesJournal of Neuroscience Research
accessLevelRestricted
2020 305 2
Pain interventions in adults with intellectual disability: A scoping review and pharmacological considerationsEuropean Journal of Pain
accessLevelRestricted
2020 273 1
Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in ChildrenTherapeutic Drug Monitoring
accessLevelPublic
2020 442 167
TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilitiesBMJ Open
accessLevelPublic
2020 366 117
Gender Differences in Cardiovascular Pharmacotherapy-the Example of Hypertension: A Mini ReviewFrontiers in Pharmacology
accessLevelPublic
2020 265 184
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective StudyJournal of Personalized Medicine
accessLevelPublic
2020 347 89
Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva CocktailJournal of Personalized Medicine
accessLevelPublic
2019 461 199
Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approachesClinical Pharmacokinetics
accessLevelRestricted
2019 416 3
Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patientsPLOS ONE
accessLevelPublic
2019 385 227
Safety issues of pharmacological acute pain treatment in childrenClinical Pharmacology and Therapeutics
accessLevelRestricted
2019 398 4
A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorderBMC Psychiatry
accessLevelPublic
2019 507 739
Liquid Chromatography-Tandem Mass Spectrometry Method for Ticagrelor and its Active Metabolite Determination in Human Plasma: Application to a Pharmacokinetic StudyCurrent Analytical Chemistry
accessLevelRestricted
2019 450 1
Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?International Journal of Clinical Pharmacy
accessLevelPublic
2019 318 278
Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxinsBasic & Clinical Pharmacology & Toxicology
accessLevelRestricted
2019 461 4
Pourquoi proposer la thérapie cognitivo-comportementale dans les douleurs chroniques ?Revue médicale suisse
accessLevelPublic
2019 481 510
Physiologically-based pharmacokinetic modeling for the prediction of CYP2D6-mediated gene-drug-drug interactionsCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2019 400 251
Perioperative intravenous low-dose ketamine for neuropathic pain after major lower back surgery: A randomized, placebo-controlled studyEuropean Journal of Pain
accessLevelRestricted
2019 391 2
Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modelingPediatric Research
accessLevelRestricted
2019 326 2
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active MetabolitesClinical Pharmacokinetics
accessLevelPublic
2018 719 721
Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical PerspectivesClinical Pharmacokinetics
accessLevelPublic
2018 511 707
Gestion de la douleur aiguë chez les patients sous traitements de substitution aux opioïdesRevue médicale suisse
accessLevelPublic
2018 672 416
Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory SettingJournal of Clinical Psychiatry
accessLevelRestricted
2018 483 0
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp softwareBiopharmaceutics & Drug Disposition
accessLevelRestricted
2018 617 12
Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomesBasic & Clinical Pharmacology & Toxicology
accessLevelPublic
2018 504 508
When the Safe Alternative Is Not That Safe: Tramadol Prescribing in ChildrenFrontiers in Pharmacology
accessLevelPublic
2018 543 290
Prescription des opioïdes chez les patients vulnérables : les enfants et les personnes âgées. Recommandations pratiquesRevue médicale suisse
accessLevelPublic
2018 583 568
Severe and persistent morphine-induced respiratory depression associated with ATP-Binding Cassette Subfamily B Member 1 and catechol-O-methyltransferase genetic defects: A case reportEuropean Journal of Anaesthesiology
accessLevelPublic
2018 438 318
Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)BMC Pharmacology & Toxicology
accessLevelPublic
2017 507 188
Impact of CYP2D6 functional allelic variations on phenoconversion and drug-drug interactionsClinical Pharmacology and Therapeutics
accessLevelRestricted
2017 485 5
Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferasesJournal of pharmaceutical and biomedical analysis
accessLevelPublic
2017 650 681
Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective studyPharmacological research
accessLevelPublic
2017 652 172
"Late" Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer NewbornFrontiers in Pharmacology
accessLevelPublic
2017 625 212
Impact d'une réconciliation médicamenteuse par un pharmacien lors de l'admission dans un service de médecine interneLe Pharmacien Hospitalier et Clinicien
accessLevelPublic
2017 282 215
Hepatocyte Concentrations of Indocyanin Green (ICG) Reflects Transfer Rates Across Membrane TransportersBasic & clinical pharmacology & toxicology
accessLevelRestricted
2017 534 3
PIM-Check: development of an international prescription-screening checklist designed by a Delphi method for internal medicine patientsBMJ Open
accessLevelPublic
2017 761 394
Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized MedicineJournal of Pharmaceutical Sciences
2017 481 0
Meta-xylene: identification of a new antigenic entity in hypersensitivity reactions to local anestheticsJournal of allergy and clinical immunology. In practice
accessLevelRestricted
2016 654 1
Le coût, ce n'est pas tout…à propos des médicaments génériquesRevue médicale suisse
accessLevelRestricted
2016 441 3
Prescriptions médicamenteuses potentiellement inappropriées en gériatrie: quels outils utiliser pour les détecter?La Presse médicale
accessLevelRestricted
2016 625 8
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic DefectFrontiers in pharmacology
accessLevelPublic
2016 494 219
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesiaNeuropharmacology
accessLevelPublic
2016 580 298
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary ReportThe New England journal of medicine
accessLevelPublic
2016 906 262
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approachClinical pharmacology and therapeutics
accessLevelPublic
2016 655 725
Pharmacogenomics of Oral Antithrombotic DrugsCurrent pharmaceutical design
2016 616 0
Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cellsFundamental & clinical pharmacology
accessLevelRestricted
2016 614 21
Severe Vincristine-Induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case StudyClinical therapeutics
accessLevelRestricted
2016 547 2
Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling MethodBasic & clinical pharmacology & toxicology
accessLevelPublic
2016 667 485
Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelinesPharmacology research & perspectives
accessLevelPublic
2016 681 291
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patientsMultiple sclerosis
accessLevelRestricted
2015 638 1
Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant PrescriptionCurrent drug metabolism
accessLevelRestricted
2015 581 3
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialLancet. Infectious diseases
accessLevelRestricted
2015 688 0
Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss CohortPloS one
accessLevelPublic
2015 597 270
Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further ImprovementsClinical therapeutics
accessLevelRestricted
2015 701 6
Assessing the affective load in the narratives of women suffering from fibromyalgia: the clinicians' appraisalHealth expectations
accessLevelRestricted
2015 686 1
P-glycoprotein: a clue to vitamin K antagonist stabilizationPharmacogenomics
accessLevelRestricted
2015 692 0
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-upJournal of neuroimmunology
accessLevelRestricted
2015 592 1
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-ReviewCurrent drug metabolism
accessLevelRestricted
2015 635 6
Prescription d'antidépresseurs dans le traitement de la douleur : rôle de la pharmacogénétiqueRevue médicale suisse
accessLevelRestricted
2015 555 1
Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiquesRevue médicale suisse
accessLevelRestricted
2015 685 5
Use of metamizole in children and the risk of agranulocytosis: Is the benefit worth the risk?European journal of anaesthesiology
accessLevelRestricted
2015 559 4
Drug-related problems identification in general internal medicine: The impact and role of the clinical pharmacist and pharmacologistEuropean journal of internal medicine
accessLevelRestricted
2015 729 6
Is pholcodine a dangerous cough suppressant?European journal of anaesthesiology
accessLevelRestricted
2015 620 1
GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteersPain
accessLevelRestricted
2015 617 3
Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a reviewCurrent drug metabolism
2014 648 0
Incorporation of Flurbiprofen in a 4-Drug Cytochrome P450 Phenotyping CocktailBasic & clinical pharmacology & toxicology
accessLevelRestricted
2014 641 4
Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newbornsTherapeutic drug monitoring
accessLevelRestricted
2014 769 3
Snapshot of Prescribing Practice for Clopidogrel and Esomeprazole Co-Prescription and Cost Evaluation of Guidelines ApplicationValue in health
accessLevelPublic
2014 513 215
Geneva Cocktail for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood SpotsClinical pharmacology and therapeutics
accessLevelPublic
2014 909 387
Improving the primary care physicians' decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening toolHealth and quality of life outcomes
accessLevelPublic
2014 597 352
Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activityAIDS research and therapy
accessLevelPublic
2014 720 926
Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic ModelCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2014 652 258
Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasmaBioanalysis
accessLevelRestricted
2014 756 5
Central Pain Sensitization, COMT Val158Met Polymorphism, and Emotional Factors in FibromyalgiaThe journal of pain
accessLevelRestricted
2014 722 2
Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospitalEuropean journal of clinical pharmacology
accessLevelPublic
2013 866 629
Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic StudyBasic & clinical pharmacology & toxicology
accessLevelPublic
2013 635 366
Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell modelBasic & clinical pharmacology & toxicology
accessLevelRestricted
2013 586 3
Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteersBasic & clinical pharmacology & toxicology
accessLevelPublic
2013 650 408
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trialPain physician
accessLevelPublic
2013 616 1,075
Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute painPain physician
accessLevelPublic
2013 783 670
Applications of CYP450 Testing in the Clinical SettingMolecular diagnosis & therapy
accessLevelPublic
2013 753 847
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatmentPharmacogenomics
accessLevelRestricted
2013 674 0
Primary attributions in women suffering fibromyalgia emphasize the perception of a disruptive onset for a long-lasting pain problemJournal of psychosomatic research
accessLevelPublic
2013 667 855
Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled studyPloS one
accessLevelPublic
2013 651 419
Transcriptional regulation of CYP2C19 and its role in altered enzyme activityCurrent drug metabolism
accessLevelRestricted
2012 597 0
Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patientAIDS
accessLevelPublic
2012 624 565
Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphismHealth psychology review
accessLevelPublic
2012 807 614
Quel programme informatique de détection des interactions médicamenteuses néfastes ?Revue médicale suisse
accessLevelPublic
2012 966 944
Representations of symptom history in women with fibromyalgia vs chronic low back pain: a qualitative studyPain medicine
accessLevelRestricted
2012 689 0
Effets indésirables des inhibiteurs de la pompe à proton: faut-il craindre de les prescrire au long cours ?La Revue de médecine interne
accessLevelPublic
2012 757 1,637
Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteersChimia
accessLevelPublic
2012 795 1,133
Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireviewBasic & clinical pharmacology & toxicology
accessLevelPublic
2012 644 677
Fracture atypique du fémur sous bisphosphonates, un effet indésirable à ne pas manquerRevue médicale suisse
accessLevelRestricted
2012 608 0
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitroBritish journal of pharmacology
accessLevelRestricted
2012 577 0
Pharmacovigilance in pregnancy: adverse drug reactions associated with fetal disordersJournal of perinatal medicine
accessLevelPublic
2012 745 1,390
Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spotClinical pharmacology and therapeutics
2012 639 0
Analgesics in patients with hepatic impairment: pharmacology and clinical implicationsDrugs
accessLevelRestricted
2012 695 3
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionJournal of viral hepatitis
accessLevelRestricted
2012 654 0
A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometryRCM. Rapid communications in mass spectrometry
accessLevelPublic
2012 835 823
Rotation des opioïdes : de la théorie à la pratique Recommandations interdisciplinaires du réseau douleur des HUGRevue médicale suisse
accessLevelRestricted
2011 726 1
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsHaematologica
accessLevelPublic
2011 1,038 594
Effet placebo analgésique : apport des neurosciencesRevue médicale suisse
accessLevelRestricted
2011 635 2
A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combinationBasic & clinical pharmacology & toxicology
accessLevelRestricted
2011 672 0
Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patientsMetabolism, clinical and experimental
2011 678 0
Le placebo, un allié mésestimé..Revue médicale suisse
accessLevelPublic
2011 759 262
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyArthritis and rheumatism
accessLevelRestricted
2011 862 8
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic painNeuropharmacology
accessLevelPublic
2011 801 625
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemiaPharmacogenomics
accessLevelRestricted
2011 943 6
Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metaboliteJournal of pharmaceutical and biomedical analysis
accessLevelPublic
2011 733 818
Effect of topical morphine (mouthwash) on oral pain due to chemotherapy- and/or radiotherapy-induced mucositis: a randomized double-blinded studyJournal of palliative medicine
accessLevelRestricted
2010 755 0
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodoneBritish journal of pharmacology
accessLevelRestricted
2010 856 2
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variabilityCurrent drug metabolism
2010 659 0
Is a bird in the hand still worth two in the bush?European journal of anaesthesiology
accessLevelRestricted
2010 525 1
Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safetyBritish journal of pharmacology
accessLevelRestricted
2010 633 1
Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoproteinBasic & clinical pharmacology & toxicology
accessLevelRestricted
2009 624 2
Douleurs chroniques et dépression: un aller-retour ?Revue médicale suisse
accessLevelRestricted
2009 668 0
Modulation cognitive et émotionnelle de la douleur: mécanismes de certaines approches cliniques révélés par les neurosciencesRevue médicale suisse
accessLevelRestricted
2009 704 12
Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic studyJournal of chromatography
accessLevelRestricted
2009 554 0
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype predictionPharmacogenomics journal
accessLevelRestricted
2009 898 0
Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospitalDrug safety
accessLevelRestricted
2009 614 0
P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexoneFundamental & clinical pharmacology
accessLevelRestricted
2009 663 0
Pharmacogenetics of analgesics: toward the individualization of prescriptionPharmacogenomics
2008 560 0
Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteersDrug metabolism letters
2008 849 0
Les toxidermies médicamenteusesRevue médicale suisse
accessLevelRestricted
2008 644 0
New approaches to the pharmacotherapy of neuropathic painExpert review of clinical pharmacology
2008 578 0
La prescription « off-label »Revue médicale suisse
accessLevelRestricted
2008 665 0
Lack of interaction of the NMDA receptor antagonists dextromethorphan and dextrorphan with P-glycoproteinCurrent drug metabolism
accessLevelRestricted
2008 642 4
Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children: a randomized trialJAMA
accessLevelRestricted
2008 784 4
Prise en charge médicamenteuse de la douleur neuropathique : quelle place pour les traitements topiques?Revue médicale suisse
accessLevelRestricted
2008 413 0
Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometryClinical biochemistry
accessLevelRestricted
2008 656 0
Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay techniqueClinical biochemistry
accessLevelRestricted
2008 651 1
Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patientsJournal of chromatography. B
accessLevelRestricted
2008 611 4
Automédication chez les sans-papiers latino-américains : entre le nécessaire et l'inappropriéRevue médicale suisse
2007 417 0
Detecting drug interactions using personal digital assistants in an out-patient clinicQJM
accessLevelPublic
2007 422 199
Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacologyExpert opinion on drug safety
accessLevelPublic
2007 528 601
Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approachJournal of chromatography. B
accessLevelRestricted
2007 559 0
Emergency liver transplantation in amodiaquine-induced fulminant hepatitisThe American journal of tropical medicine and hygiene
accessLevelPublic
2007 665 328
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover studyClinical therapeutics
accessLevelRestricted
2007 758 0
Effets indésirables des inhibiteurs de la pompe à protons (IPP)Revue médicale suisse
2007 528 0
Anticoagulation orale et pharmacogénétique : perspectives pour la pratique cliniqueRevue médicale suisse
2007 403 0
Patients' representations of antidepressants: a clue to nonadherence?The Clinical journal of pain
accessLevelRestricted
2007 510 1
Prescription en médecine de premier recours: l'intérêt d'une liste de médicamentsRevue médicale suisse
2006 447 0
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosisEuropean journal of clinical pharmacology
accessLevelPublic
2006 646 406
Entre sel et gènes ou pharmacogénomique des antihypertenseursRevue médicale suisse
2006 401 0
Prise en charge médicamenteuse des troubles psychologiques et comportementaux lies à la démenceRevue médicale suisse
2006 476 0
Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factorsArchives of internal medicine
accessLevelPublic
2006 478 362
Polymorphisme génétique et interactions médicamenteuses: leur importance dans le traitement de la douleurCanadian journal of anaesthesia
accessLevelPublic
2005 541 397
Systemic allergic reaction and diffuse bone pain after exposure to a preparation of betamethasoneEuropean journal of internal medicine
accessLevelRestricted
2005 434 0
Sélection d'un médicament dans une classe thérapeutique donnée : l'exemple des «inhibiteurs de l'HMG-CoA réductase»Revue médicale suisse
2005 376 0
Le traitement de l'hypertension artérielle : un défi pour le praticienRevue médicale suisse
2005 467 0
SIADH consecutive to ciprofloxacin intakeEuropean journal of internal medicine
accessLevelRestricted
2004 480 2
Fibromyalgia: a randomised, controlled trial of a treatment programme based on self managementAnnals of the rheumatic diseases
accessLevelRestricted
2004 502 2
Influence du cycle mentruel sur le seuil de la douleur expérimentaleDouleur et analgésie
accessLevelRestricted
2004 584 1
QT interval prolongation in patients on methadone with concomitant drugsJournal of clinical psychopharmacology
accessLevelRestricted
2004 468 0
Codeine intoxication associated with ultrarapid CYP2D6 metabolismThe New England journal of medicine
accessLevelRestricted
2004 546 1
Neurophysiologic evidence for a central sensitization in patients with fibromyalgiaArthritis and rheumatism
accessLevelPublic
2003 535 750
Clinical pharmacology and rationale of analgesic combinationsEuropean journal of anaesthesiology. Supplement
2003 393 0
Rofecoxib interaction with oral anticoagulant acenocoumarolEuropean journal of clinical pharmacology
accessLevelPublic
2003 474 228
Advances with analgesics and NSAIDs for the treatment of spinal disordersBaillière's best practice & research. Clinical rheumatology
accessLevelPublic
2002 484 391
Drug-induced epidermolysis bullosa acquisita with antibodies to type VII collagenJournal of the American Academy of Dermatology
accessLevelRestricted
2002 511 0
Hepatitis associated with Kava, a herbal remedy for anxietyBMJ. British medical journal
accessLevelPublic
2001 649 422
Effet analgesique des opiaces en usage cutane: quelle est leur efficacite?Thérapie
2001 424 0
The tramadol optionEuropean journal of pain
2000 445 0
Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphanThe Journal of pharmacology and experimental therapeutics
accessLevelPublic
1999 364 192
Anaphylactic shock induced by intraurethral use of chlorhexidineAllergy
accessLevelPublic
1999 412 435
Use of the label "litigation neurosis" in patients with somatoform pain disorderGeneral hospital psychiatry
accessLevelPublic
1998 462 189
Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflexEuropean journal of clinical pharmacology
accessLevelRestricted
1998 522 0
Facteurs associes aux douleurs cancereuses refractairesSchweizerische medizinische Wochenschrift
accessLevelPublic
1998 440 53
Sodium stibogluconate (pentostan) overdose in a patient with acquired immunodeficiency syndromeTherapeutic drug monitoring
1998 448 0
Influence du sexe sur la plainte douloureuseSchweizerische medizinische Wochenschrift
1998 433 0
Influences génétiques et environnementales sur la neuromodulation et l'effet antinociceptif du dextromethorphanSchweizerische medizinische Wochenschrift
1998 414 0
Rhabdomyolysis after correction of hyponatremia due to psychogenic polydipsia possibly complicated by clozapineThe annals of pharmacotherapy
1998 439 0
Pharmacologie du tramadolDrugs
accessLevelRestricted
1997 735 2
Stereoselective interaction between piroxicam and acenocoumarolBritish journal of clinical pharmacology
accessLevelRestricted
1996 638 7
Atteintes hepatiques medicamenteuses, il faut y penser !Schweizerische medizinische Wochenschrift
1996 340 0
Contribution of monoaminergic modulation to the analgesic effect of tramadolBritish journal of clinical pharmacology
accessLevelPublic
1996 496 280
Systemic clonidine differentially modulates the abnormal reactions to mechanical and thermal stimuli in rats with peripheral mononeuropathyPain
accessLevelRestricted
1995 429 0
Influence of the sympathetic nervous system in the development of abnormal pain-related behaviours in a rat model of neuropathic painNeuroscience
accessLevelPublic
1995 508 400
Time-course of nociceptive disorders induced by chronic loose ligatures of the rat sciatic nerve and changes of the acetylcholinesterase transport along the ligated nervePain
accessLevelRestricted
1994 492 0
Facteurs predictifs d'une resistance au traitement des douleurs neuropathiquesSchweizerische medizinische Wochenschrift
1994 400 0
Arret de travail et comportement-maladie chez des patients souffrant de douleurs chroniquesSchweizerische medizinische Wochenschrift
1994 471 0
Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic ratsPain
accessLevelRestricted
1994 413 0
The pharmacology of tramadolDrugs
1994 480 0
Evaluation de la douleur chronique des patients d'age geriatriqueSchweizerische medizinische Wochenschrift
1994 494 0
Quelle posologie antalgique du paracetamol?Schweizerische medizinische Wochenschrift
1994 450 0
Pericardite recidivante induite par la mesalazine (5-ASA)Thérapie
1994 425 0
Opposite effects of axon damage on heat shock proteins (hsp 70) and ubiquitin contents in motor neurons of neuropathic ratsNeuroscience letters
1993 420 0
The highly selective delta agonist BUBU induces an analgesic effect in normal and arthritic rat and this action is not affected by repeated administration of low doses of morphineBrain research
accessLevelPublic
1993 409 95
Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic painPain
1993 411 0
In vitro forecasting of drugs that may interfere with codeine bioactivationEuropean journal of drug metabolism and pharmacokinetics
accessLevelPublic
1992 408 110
Impact of environmental and genetic factors on codeine analgesiaEuropean journal of clinical pharmacology
accessLevelRestricted
1991 413 0
Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)Biochemical and biophysical research communications
accessLevelPublic
1988 411 485
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack